BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32903408)

  • 1. Lysine Acetyltransferase Inhibitors From Natural Sources.
    Fiorentino F; Mai A; Rotili D
    Front Pharmacol; 2020; 11():1243. PubMed ID: 32903408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysine acetyltransferase inhibitors: structure-activity relationships and potential therapeutic implications.
    Fiorentino F; Mai A; Rotili D
    Future Med Chem; 2018 May; 10(9):1067-1091. PubMed ID: 29676588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent spotlight: small-molecule lysine acetyltransferase inhibitors (KATi).
    Brown JA
    Pharm Pat Anal; 2020 Jan; 9(1):17-28. PubMed ID: 32008421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cancer using KAT inhibitors to mimic lethal knockouts.
    Brown JA; Bourke E; Eriksson LA; Kerin MJ
    Biochem Soc Trans; 2016 Aug; 44(4):979-86. PubMed ID: 27528742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of histone acetyltransferase inhibitors in cancer therapy.
    Shanmugam MK; Dharmarajan A; Warrier S; Bishayee A; Kumar AP; Sethi G; Ahn KS
    Adv Protein Chem Struct Biol; 2021; 125():149-191. PubMed ID: 33931138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine Acetyltransferases (KATs) in Disguise: Diseases Implications.
    Srivastava S; Kumar S; Bhatt R; Ramachandran R; Trivedi AK; Kundu TK
    J Biochem; 2023 May; 173(6):417-433. PubMed ID: 36913740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical Biology Approaches for Investigating the Functions of Lysine Acetyltransferases.
    He M; Han Z; Liu L; Zheng YG
    Angew Chem Int Ed Engl; 2018 Jan; 57(5):1162-1184. PubMed ID: 28786225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Versatility of ARD1/NAA10-mediated protein lysine acetylation.
    Vo TTL; Jeong CH; Lee S; Kim KW; Ha E; Seo JH
    Exp Mol Med; 2018 Jul; 50(7):1-13. PubMed ID: 30054464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifications of cell signalling and redox balance by targeting protein acetylation using natural and engineered molecules: implications in cancer therapy.
    Venkateswaran K; Verma A; Bhatt AN; Agrawala PK; Raj HG; Malhotra S; Prasad AK; Wever OD; Bracke ME; Saso L; Parmar VS; Shrivastava A; Dwarakanath BS
    Curr Top Med Chem; 2014; 14(22):2495-507. PubMed ID: 25478886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-scale analysis of regulatory protein acetylation enzymes from photosynthetic eukaryotes.
    Uhrig RG; Schläpfer P; Mehta D; Hirsch-Hoffmann M; Gruissem W
    BMC Genomics; 2017 Jul; 18(1):514. PubMed ID: 28679357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidic Mobility Shift Profiling of Lysine Acetyltransferases Enables Screening and Mechanistic Analysis of Cellular Acetylation Inhibitors.
    Sorum AW; Shrimp JH; Roberts AM; Montgomery DC; Tiwari NK; Lal-Nag M; Simeonov A; Jadhav A; Meier JL
    ACS Chem Biol; 2016 Mar; 11(3):734-41. PubMed ID: 26428393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fluorescence-based acetylation assay using thiol-sensitive probes.
    Gao T; Yang C; Zheng YG
    Methods Mol Biol; 2013; 981():229-38. PubMed ID: 23381866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysine acetylation in obesity, diabetes and metabolic disease.
    Iyer A; Fairlie DP; Brown L
    Immunol Cell Biol; 2012 Jan; 90(1):39-46. PubMed ID: 22083525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of small-molecule inhibitors of lysine acetyltransferases.
    Liao D
    Methods Mol Biol; 2015; 1238():539-48. PubMed ID: 25421679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoproteomic profiling of lysine acetyltransferases highlights an expanded landscape of catalytic acetylation.
    Montgomery DC; Sorum AW; Meier JL
    J Am Chem Soc; 2014 Jun; 136(24):8669-76. PubMed ID: 24836640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant Effects of Putative Lysine Acetyltransferase Inhibitors in Biochemical and Living Systems.
    Henry RA; Kuo YM; Siegel ZS; Yen TJ; Rhodes J; Taylor EA; Andrews AJ
    Cells; 2019 Sep; 8(9):. PubMed ID: 31480793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone lysine acetyltransferase inhibitors: an emerging class of drugs for cancer therapy.
    White J; Derheimer FA; Jensen-Pergakes K; O'Connell S; Sharma S; Spiegel N; Paul TA
    Trends Pharmacol Sci; 2024 Mar; 45(3):243-254. PubMed ID: 38383216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of In Vitro Protein Lysine Acetylation by Reversed Phase HPLC.
    Njeri CW; Ononye OE; Balakrishnan L
    Methods Mol Biol; 2019; 1983():49-56. PubMed ID: 31087292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site specificity analysis of Piccolo NuA4-mediated acetylation for different histone complexes.
    Kuo YM; Henry RA; Tan S; Côté J; Andrews AJ
    Biochem J; 2015 Dec; 472(2):239-48. PubMed ID: 26420880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping Lysine Acetyltransferase-Ligand Interactions by Activity-Based Capture.
    Montgomery DC; Meier JL
    Methods Enzymol; 2016; 574():105-123. PubMed ID: 27423859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.